logo

Japan Insulin Infusion Pump Market Size (2024 - 2029)

The Japan insulin infusion pump market is anticipated to experience growth over the forecast period, driven by factors such as the country's aging population and increasing diabetes incidence linked to lifestyle changes. The market size is influenced by the rising number of diabetes diagnoses, particularly through metabolic syndrome screenings, which have become more prevalent in addressing lifestyle-related health issues. Despite the growing need, the penetration of insulin pumps among type 1 diabetes patients remains limited, indicating potential for market expansion.

Home Market Analysis Healthcare Research Medical Devices Research Japan Insulin Infusion Pump Market Market Size

Market Size of Japan Insulin Infusion Pump Industry

Japan Insulin Infusion Pump Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Market Size (2024) USD 55.96 Million
Market Size (2029) USD 68.41 Million
CAGR (2024 - 2029) > 4.10 %

Major Players

Japan Insulin Infusion Pump Market Major Players

*Disclaimer: Major Players sorted in no particular order

Japan Insulin Infusion Pump Market Analysis

The Japan Insulin Infusion Pump Market size is estimated at USD 53.76 million in 2023, and is expected to reach USD 65.72 million by 2028, growing at a CAGR of greater than 4.10% during the forecast period (2023-2028).

The Japanese market for diabetes insulin infusion pumps is witnessing a robust growth trajectory, fueled by the increase in diabetes cases and proactive industry initiatives, including expanding product portfolios and the increasing prevalence of diabetes.

With Japan's diabetic population on the rise, the demand for insulin infusion pumps that are crucial for managing blood glucose levels is poised for a significant uptick. Data from the IDF Diabetes Atlas highlighted the widespread prevalence of diabetes across various age brackets, with a pronounced concentration among the working-age segment. In 2022, Japan reported 5.5 thousand diabetics under 20, 43.3 thousand aged 20-59, and 30.5 thousand above 60. Such a high concentration of diabetic people in the working-age group affects the nation's healthcare expenditure. According to IDF Diabetes Atlas, Japan's diabetes cases are expected to rise further.

As the diabetic populace expands, Japan is experiencing a surge in new product introductions and guideline updates. For instance, in February 2023, Medtronic Japan Co. Ltd secured manufacturing and sales approval for the MiniMed 780G System. This marked a milestone as Japan's first insulin pump featuring the Advanced Hybrid Closed Loop technology with automatic insulin injection for basal and correction insulin.

The growing prevalence of diabetes in Japan is driving significant market growth. Market players are responding with innovative products and expanded capacities, positioning the market for continued expansion.

Japan Insulin Infusion Pump Industry Segmentation

An insulin pump is used to deliver insulin to achieve proper blood sugar control and minimize hypoglycemia's effects. The pump comprises a pump reservoir like an insulin cartridge, a battery-operated pump, and a computer chip that allows the user to control the exact amount of insulin being delivered. The pump is attached to a thin plastic tube (an infusion set) with a soft cannula (or needle) at the end through which insulin passes.

Japan’s insulin infusion pump market is segmented by component and end user. By component, the market is segmented into pump device, infusion set, and reservoir. By end user, the market is segmented into hospitals/clinics, home care settings, and others. The report offers the value (USD) for all the above segments.

By Product Type
Insulin Pump Device
Infusion Set
Reservoir
By End User
Hospitals/Clinics
Home Care
Others
Need A Different Region Or Segment?
Customize Now

Japan Insulin Infusion Pump Market Size Summary

The Japan insulin infusion pump market is poised for steady growth, driven by the increasing prevalence of diabetes, particularly type 1 and type 2, among the aging population and those with sedentary lifestyles. The market is characterized by the adoption of advanced insulin delivery systems, which offer more precise and less painful alternatives to traditional injection methods. Insulin pumps, which mimic the pancreas's natural insulin delivery, are becoming more popular due to their ability to maintain stable blood glucose levels and improve the quality of life for diabetes patients. Despite the benefits, the penetration of insulin pumps in Japan remains limited, with a relatively small number of users compared to the total diabetes population, indicating significant growth potential.

The market landscape is dominated by a few key players, both international and local, such as Medtronic PLC, Insulet Corporation, Ypsomed, Ascensia Diabetes Care, and Tandem Diabetes Care. These companies are actively involved in strategic initiatives, including acquisitions and product launches, to enhance their market presence and expand their product offerings. The competitive environment is shaped by the need for innovation and the integration of continuous glucose monitoring systems with insulin pumps, which are expected to drive market expansion. However, challenges such as dietary changes, lack of standardized diabetes education, and delayed treatment post-screening continue to impact the market's growth trajectory.

Explore More

Japan Insulin Infusion Pump Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Rising Diabetes Prevalence in Japan

      2. 1.2.2 Government Support Initiatives to Construct the Spread of Diabetes

    3. 1.3 Market Restraints

      1. 1.3.1 Limited Awareness About the Pump and Related-Technology

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Bargaining Power of Suppliers

      2. 1.4.2 Bargaining Power of Consumers

      3. 1.4.3 Threat of New Entrants

      4. 1.4.4 Threat of Substitute Products and Services

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size - Value USD)

    1. 2.1 By Product Type

      1. 2.1.1 Insulin Pump Device

      2. 2.1.2 Infusion Set

      3. 2.1.3 Reservoir

    2. 2.2 By End User

      1. 2.2.1 Hospitals/Clinics

      2. 2.2.2 Home Care

      3. 2.2.3 Others

Japan Insulin Infusion Pump Market Size FAQs

The Japan Insulin Infusion Pump Market size is expected to reach USD 55.96 million in 2024 and grow at a CAGR of greater than 4.10% to reach USD 68.41 million by 2029.

In 2024, the Japan Insulin Infusion Pump Market size is expected to reach USD 55.96 million.

Japan Insulin Infusion Pump Market Report Snapshots

Japan Insulin Infusion Pump Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)